Two Sigma Investments
BBNX

Two Sigma Investments’s Beta Bionics BBNX Stock Holding History

Two Sigma Investments’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$656K Sell
65,495
-345,108
-84% -$5.1M ﹤0.01% 3542
2025
Q4 		$12.5M Buy
410,603
+246,839
+151% +$6.59M 0.02% 981
2025
Q3 		$3.25M Buy
163,764
+142,468
+669% +$2.5M ﹤0.01% 1793
2025
Q2 		$310K Buy
21,296
+545
+3% +$7.71K ﹤0.01% 2780
2025
Q1 		$254K Buy
+20,751
New +$387K ﹤0.01% 2779

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments's BBNX Position: Q1 2026 in Review

Two Sigma Investments reduced its Beta Bionics (BBNX) stake by 84% in Q1 2026, selling an estimated $5.1M and leaving 65,495 shares worth $656K. The position accounts for ﹤0.01% of the portfolio, ranked #3542.

Two Sigma Investments first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $12.5M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Two Sigma Investments held 65,495 shares of Beta Bionics worth $656K as of Q1 2026.
  • Two Sigma Investments sold 345,108 Beta Bionics shares in Q1 2026, an estimated $5.1M.
  • Beta Bionics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3542 holding.
  • Two Sigma Investments first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Two Sigma Investments's Beta Bionics position peaked at $12.5M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.